Drug short­ages re­main low in 2021 as FDA's pre­ven­tion ef­forts grow, re­port to Con­gress says

Sup­ply chain sna­fus, high-pro­file drug and vac­cine short­ages and qual­i­ty is­sues (e.g. Emer­gent’s Bal­ti­more site) have played a ma­jor role dur­ing the pan­dem­ic so far …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.